Name | Number of supported studies | Average coverage | |
---|---|---|---|
amacrine cell | 5 studies | 46% ± 17% | |
retina horizontal cell | 5 studies | 41% ± 19% | |
Mueller cell | 5 studies | 38% ± 17% | |
glycinergic amacrine cell | 4 studies | 40% ± 11% | |
astrocyte | 4 studies | 38% ± 18% | |
retinal pigment epithelial cell | 4 studies | 35% ± 10% | |
retinal bipolar neuron | 3 studies | 44% ± 9% | |
OFF-bipolar cell | 3 studies | 28% ± 15% | |
GABAergic amacrine cell | 3 studies | 21% ± 4% | |
retinal ganglion cell | 3 studies | 25% ± 10% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
eye | 6 studies | 24% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
eye | 0% | 0 | 0 / 0 | 76% | 3.69 | 61 / 80 |
brain | 54% | 1176.82 | 1414 / 2642 | 9% | 0.60 | 62 / 705 |
pancreas | 18% | 25.10 | 59 / 328 | 34% | 1.55 | 60 / 178 |
adrenal gland | 0% | 0.82 | 1 / 258 | 47% | 7.20 | 108 / 230 |
bladder | 0% | 0 | 0 / 21 | 33% | 2.39 | 166 / 504 |
ovary | 0% | 0 | 0 / 180 | 32% | 9.01 | 137 / 430 |
breast | 3% | 4.21 | 15 / 459 | 28% | 3.78 | 318 / 1118 |
uterus | 1% | 0.66 | 1 / 170 | 25% | 4.05 | 114 / 459 |
lung | 2% | 2.10 | 12 / 578 | 23% | 1.67 | 263 / 1155 |
esophagus | 1% | 1.15 | 11 / 1445 | 23% | 2.15 | 43 / 183 |
intestine | 0% | 0 | 0 / 966 | 13% | 0.73 | 71 / 527 |
stomach | 0% | 0.86 | 1 / 359 | 12% | 0.78 | 35 / 286 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.89 | 4 / 45 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.20 | 2 / 29 |
liver | 0% | 0 | 0 / 226 | 6% | 0.22 | 26 / 406 |
skin | 1% | 0.71 | 11 / 1809 | 6% | 0.44 | 26 / 472 |
peripheral blood | 6% | 25.29 | 56 / 929 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 4% | 0.64 | 32 / 901 |
adipose | 0% | 0.78 | 6 / 1204 | 0% | 0 | 0 / 0 |
thymus | 0% | 1.07 | 3 / 653 | 0% | 0 | 0 / 605 |
spleen | 0% | 0.29 | 1 / 241 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.21 | 2 / 803 | 0% | 0 | 0 / 0 |
prostate | 0% | 0 | 0 / 245 | 0% | 0.00 | 1 / 502 |
blood vessel | 0% | 0.18 | 2 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_2000177 | Biological process | regulation of neural precursor cell proliferation |
GO_0003404 | Biological process | optic vesicle morphogenesis |
GO_0007601 | Biological process | visual perception |
GO_1990086 | Biological process | lens fiber cell apoptotic process |
GO_0021846 | Biological process | cell proliferation in forebrain |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0021978 | Biological process | telencephalon regionalization |
GO_0021798 | Biological process | forebrain dorsal/ventral pattern formation |
GO_1901987 | Biological process | regulation of cell cycle phase transition |
GO_0001654 | Biological process | eye development |
GO_1902692 | Biological process | regulation of neuroblast proliferation |
GO_0002070 | Biological process | epithelial cell maturation |
GO_0009946 | Biological process | proximal/distal axis specification |
GO_0045665 | Biological process | negative regulation of neuron differentiation |
GO_0061074 | Biological process | regulation of neural retina development |
GO_1902742 | Biological process | apoptotic process involved in development |
GO_0002088 | Biological process | lens development in camera-type eye |
GO_0007420 | Biological process | brain development |
GO_0021983 | Biological process | pituitary gland development |
GO_0070306 | Biological process | lens fiber cell differentiation |
GO_0014016 | Biological process | neuroblast differentiation |
GO_0021537 | Biological process | telencephalon development |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0042127 | Biological process | regulation of cell population proliferation |
GO_0097402 | Biological process | neuroblast migration |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0001222 | Molecular function | transcription corepressor binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SIX3 |
Protein name | Homeobox protein SIX3 Homeobox protein SIX3 (Sine oculis homeobox homolog 3) SIX3 protein Sine oculis homeobox-like protein 3 SIX homeobox 3 |
Synonyms | |
Description | FUNCTION: Transcriptional regulator which can act as both a transcriptional repressor and activator by binding a ATTA homeodomain core recognition sequence on these target genes. During forebrain development represses WNT1 expression allowing zona limitans intrathalamica formation and thereby ensuring proper anterio-posterior patterning of the diencephalon and formation of the rostral diencephalon. Acts as a direct upstream activator of SHH expression in the rostral diencephalon ventral midline and that in turn SHH maintains its expression. In addition, Six3 activity is required for the formation of the telencephalon. During postnatal stages of brain development is necessary for ependymal cell maturation by promoting the maturation of radial glia into ependymal cells through regulation of neuroblast proliferation and migration. Acts on the proliferation and differentiation of neural progenitor cells through activating transcription of CCND1 and CCND2. During early lens formation plays a role in lens induction and specification by activating directly PAX6 in the presumptive lens ectoderm. In turn PAX6 activates SIX3 resulting in activation of PDGFRA and CCND1 promoting cell proliferation. Also is required for the neuroretina development by directly suppressing WNT8B expression in the anterior neural plate territory. Its action during retina development and lens morphogenesis is TLE5 and TLE4-dependent manner. Furthermore, during eye development regulates several genes expression. Before and during early lens development represses the CRYGF promoter by binding a SIX repressor element. Directly activates RHO transcription, or cooperates with CRX or NRL. Six3 functions also in the formation of the proximodistal axis of the optic cup, and promotes the formation of optic vesicles-like structures. During pituitary development, acts in parallel or alternatively with HESX1 to control cell proliferation through Wnt/beta-catenin pathway (By similarity). Plays a role in eye development by suppressing WNT1 expression and in dorsal-ventral patterning by repressing BMP signaling pathway. . |
Accessions | ENST00000260653.5 A0A1Y0ZVZ1 O95343 A0A127AXF1 A0A127AXB2 A0A1Y0ZN85 A0PJI2 A0A0D3RS46 |